课题基金 / 基金详情

SIV MOLECULAR CLONES W/ NEF MUTATIONS

SIV MOLECULAR CLONES W/ NEF MUTATIONS
带有 NEF 突变的 SIV 分子克隆
批准号:
6277920
负责人:
PAUL A LUCIW
金额:
$8.13万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 1999-04-30

项目摘要

项目成果

PAUL A LUCIW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Significance The nef gene of SIV is important for maintaining high virus load and progression to simian AIDS (SAIDS) in adult rhesus macaques. Nef of HIV and SIV contains highly conserved sequence motifs. This sudy is part of an ongoing analysis of functional domains of Nef in vitro (cell-free and tissue culture assay systems) and in vivo (macaques infected with mutant SIV nef clones). Objectives The nef gene of SIV is important for maintaining high virus load and progression to simian AIDS (SAIDS) in adult rhesus macaques. Nef of HIV and SIV contains a highly conserved src-homology region 3 (SH3)-ligand domain characterized by the pro-x-x-pro motif. The objective was to determine the importance of this motif in viral pathogesis by evaluating a mutant clone, in which both pro residues were mutated to ala residues, in vivo in macaques. Results The mutant clone SIVmac239-P104A/P107A, containing mutations in the SH3-ligand domain of Nef, was not able to interact with the Nef-activated kinase (NAK) in in vitro kinase assays. Macaques were inoculated with this mutant to test the in vivo significance of this domain. Genotypic and phenotypic reversions in nef were observed in viruses recovered from these animals. The reversions correlated with viral persistence and progression to SAIDS. Thus, the interaction of Nef with NAK is important for viral pathogenesis. Future Directions The cellular protein(s) interacting with the SH3-ligand domain of Nef remains to be identified. Novel antiviral strategies can be developed based on drugs that interact with the SH3-ligand domain of Nef. KEYWORDS SIV, viral pathogenesis
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
HHV 8 INFECTION IN RHESUS MACAQUES
PATHOGENIC CONVERSION IN SIV CLONES LACKING NEF GENE
SIV & HIV 1 RECOMBINANTS SHIVSUBTYPE E ENV
SIV & HIV 1 RECOMBINANTS SHIVNEF
海外基金